Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model (Q30992263)

28 June 2017

title

Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model (English)

1 reference

28 June 2017

0 references

Javitt JC

1

1 reference

28 June 2017

Canner JK

2

1 reference

28 June 2017

Frank RG

3

1 reference

28 June 2017

Steinwachs DM

4

1 reference

28 June 2017

Sommer A

5

1 reference

28 June 2017

publication date

1 April 1990

1 reference

28 June 2017

1 reference

28 June 2017

volume

97

1 reference

28 June 2017

issue

4

1 reference

28 June 2017

page(s)

483-94; discussion 494-5

1 reference

Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Photocoagulation for Diabetic Macular Edema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Photocoagulation for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Cost effectiveness of current approaches to the control of retinopathy in type I diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Cost-effectiveness of interventions to prevent or treat coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Incidence of diabetes mellitus by clinical type

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Retinopathy in young-onset diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

The Natural History of Retinopathy in Insulin-Dependent Juvenile-Onset Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Estimating incidence from age-specific prevalence for irreversible diseases with differential mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Relation of ocular and systemic factors to survival in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

The care of diabetic patients by ophthalmologists in New York State

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2890%2932573-3

7 January 2021

10.1016/S0161-6420(90)32573-3

Identifiers

DOI

1 reference

28 June 2017

1 reference